Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine patch for chemotherapy-induced peripheral neuropathy
NCT04468230Phase 2Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Jul 2020
- Primary completion
- May 2022
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine patch in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Virginia Commonwealth University. Started Jul 2020; status: terminated.
02
Drugs
nicotine patch
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04468230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468230.